MabPlex Earns Frost & Sullivan Award
Based on its recent analysis of the global antibody drug conjugate (ADC) contract manufacturing services market, Frost & Sullivan awarded MabPlex with the 2019 Global Growth Excellence Leadership Award. Frost & Sullivan has recognized MabPlex as one of the few large-scale, one-stop-shop ADC producers, providing services from early-stage development to commercialization. MabPlex’s proprietary conjugation platform and innovative technologies deliver novel and clinically effective ADCs for cancer therapeutics around the world. Want to read the complete 11 page Frost & Sullivan on ADC contract manufacturing services? Fill out the form below and we’ll immediately send you and email with a link.